SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe In health Mar 03, 2026, 07:00 AM By SNIPR BIOME 0 Views The Lancet Microbe publishes SNIPR001 Phase 1: safe, gut‑restricted, microbiome stable; Phase 1b HSCT trial >50% enrolled.... First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001s safety, tolerability, and restriction to the gastrointestinal tract in healthy p… [+5605 chars] health Mar 30, 2026, 03:28 AM health Mar 30, 2026, 03:21 AM health Mar 29, 2026, 10:34 PM health Mar 29, 2026, 05:34 PM health Mar 29, 2026, 12:30 PM health Mar 29, 2026, 12:22 PM health Mar 29, 2026, 12:20 PM health Mar 29, 2026, 12:18 PM health Mar 29, 2026, 12:16 PM health Mar 29, 2026, 12:16 PM SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe - FHMnews